What are the benefits of the ExoDx Prostate Test?
The ExoDx Prostate Test provides a risk assessment for finding clinically significant prostate cancer that otherwise relies on biopsy in men with an elevated PSA. Right now, there just isn’t great information that can help doctors and patients screen for and diagnose prostate cancer without the over-reliance on prostate biopsies. The EPI Test provides a painless, easy to interpret, personalized and dependable answer on whether a patient has lower risk for having aggressive prostate cancer. If your test result indicates that you are at “lower risk”, then you and your doctor (using all other clinical information including family history, prior PSA, abnormal DRE) may decide not to proceed with a prostate biopsy – avoiding the pain, complications and costs associated with a prostate biopsy.
**The ExoDx Prostate test is a simple urine test that provides actionable intelligence on biopsy decision. No digital rectal exam is required. **
The EPI Test works by analyzing prostate cancer-specific genomic biomarkers that are highly expressed during tumor cell growth found in the urine. These biomarkers are measured in a clinical laboratory and a validated algorithm calculates a score to determine a man’s risk of having aggressive or clinically significant prostate cancer.
|If your ExoDx IntelliScore is:||The Result Means This:||The intervention is this:|
|< 15.6||Low risk or benign||Potentially avoid biopsy
|> 15.6||Higher risk||Proceed to biopsy|
Should I Get The ExoDx Prostate Test?
If you are a man over the age of 50 with a prostate specific antigen (PSA) of 2- 10 ng/mL and are considering a prostate biopsy, then you should talk to your doctor or health care provider about The ExoDx ProstateTest.
The ExoDx Prostate Test will tell you if you are at risk for having high-grade prostate cancer. You and your doctor, together, can use this information to make an informed and shared decision on whether or not to proceed with a biopsy.
The ExoDx Prostate Test:
- Included in the May 2019 NCCN guidelines
- Granted Breakthrough Designation by the FDA
- Covered by Medicare
- Performed in more than 30,000 men
- Proven to avoid almost 30% of biopsies
Common Reasons for a Prostate Biopsy
A prostate biopsy is used to diagnose prostate cancer. Your doctor may recommend a prostate biopsy if any of these are present:
- Family history of prostate cancer
- Elevated or high PSA
- Increasing PSA over time
- Abnormal results from a digital rectal exam (DRE)
1 Clinical Utility Study, 2019. Manuscript submitted.